Effectiveness of a mHealth Intervention for the Treatment of Depression in People With Diabetes or Hypertension in Peru (LATIN-MHPeru)
Depression, Diabetes, Hypertension
About this trial
This is an interventional treatment trial for Depression focused on measuring Depression, Chronic diseases, Mobile technology, Clinical trial
Eligibility Criteria
Inclusion Criteria:
- Age 21 or older
- Presenting depressive symptoms (PHQ9≥10)
- Clinical diagnosis of diabetes and/or hypertension
- Able to read
Exclusion Criteria:
- If pregnant, the diagnosis of hypertension or diabetes is not related to the current pregnancy
- Moderate or severe suicide risk (Level B2 or C measured by S-RAP)
Sites / Locations
- Policlínico Bellavista
- Policlínico Hermana María Donrose Sutmöller
- Hospital Nacional Dos de Mayo
- Policlínico Juan José Rodríguez Lazo
- Hospital Nacional Arzobispo Loayza
- Hospital Nacional Cayetano Heredia
- CAP III Carabayllo
- Universidad Peruana Cayetano Heredia
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
CONEMO
Control Group
Participants in the intervention arm will receive a smartphone with CONEMO, an application with 18 sessions that are delivered 3 times a week for 6 weeks. Additionally, all study participants, including those in the intervention arm, who present a high risk of suicide and/or have a PHQ-9 score ≥20 are referred to the system for follow up. Participants with lower levels of depressive symptoms receive the recommendation of going to a mental health professional.
Participants in the control group will receive enhanced usual care. Participants who present a high risk of suicide and/or have a PHQ-9 score ≥20 are referred to the system for follow up. Participants with lower levels of depressive symptoms receive the recommendation of going to a mental health professional.